Rapid Responses to:

LETTERS: Julie C Doughty and Christopher R Wilson Tamoxifen is unproved for gynaecomastia BMJ 2003; 327: 1050-b [Full text]

Rapid Responses: Submit a response to this article

Rapid Responses published:

Tamoxifen as a first line treatment for gynaecomastia.

Edoardo Cervoni   (6 November 2003)

Tamoxifen as a first line treatment for gynaecomastia. 6 November 2003
Edoardo Cervoni, West Lancashire PCT Salaried Primary Care Doctor Ormskirk & District General Hospital , Ormskirk, Lancashire Send response to journal: Re: Tamoxifen as a first line treatment for gynaecomastia.	I do actually agree with Khan and Blamey's recommendation of tamoxifen as first line treatment of gynaecomastia. Apart from the evidence produced by the Authors and based on 135 patients (not randomised controlled clinical trials), there is a quite extensive anectodical evidence of its effectiveness. Bodybuilders have been using Tamoxifen for several years as a treatment for gynaecomastia due to steroid androgens abuse. This made of Nolvadex one of the most requested prescriptions in the black market. Competing interests: None declared